FindMyKOL

Michael Chizner, MD

Basic profile

Broward Health Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionFort Lauderdale, FL · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Chizner is a Cardiology physician affiliated with Broward Health Medical Center. OpenAlex indexes 13 publications with 471 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
13publications

Publications indexed by OpenAlex. Counts exclude supporting files.

471citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Actelion Pharmaceuticals US, Inc.
    Program year20251 payment
    $37
  • Boston Scientific Corporation
    Program year20242 payments
    $280
  • AstraZeneca Pharmaceuticals LP
    Program year20242 payments
    $250
All 9 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    68.3%
    Beta blocker21.9%
    Metoprolol Succinate53%Atenolol17%Carvedilol17%Metoprolol Tartrate13%
    Part D≥57 patients
    Statin15.9%
    Atorvastatin Calcium53%Rosuvastatin Calcium37%Pravastatin Sodium5%Simvastatin5%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    18.5%
    Factor Xa inhibitor14.9%
    Eliquis64%Xarelto36%
    Part D≥26 patients
    P2Y12 inhibitor2.6%
    Clopidogrel100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    11%
    Proton pump inhibitor6.3%
    Pantoprazole Sodium100%
    Part D≥30 patients
    Potassium supplement3.5%
    Potassium Chloride100%
    Part D≥16 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”